Page 1,261«..1020..1,2601,2611,2621,263..1,2701,280..»

Category Archives: Transhuman News

Texas City Tops the List of Dog Attacks on Postal Workers in US – Newstalk1290

Posted: June 17, 2020 at 12:56 am

Ive always thought being a mail carrier would be a cool job - except when it comes to dealing with dogs.

You definitely want your dog to provide security for your home, whether its merely to alert you to the presence of a stranger or to act as a front line of defense. But for postal workers, dogs can be a real threat. So, its important to be mindful of the safety of your mail carrier in relation to your canine buddy.

The U.S. Postal Service (USPS) released its annual list of cities with the most recorded dog attacks ahead of National Dog Bite Awareness Week, which kicks off June 14. Sadly, a whole lot of postal workers have been attacked here in Texas, with five cities ranked in the top 20 for dog attacks.

Houston had the most dog attacks in the U.S. with 85 in 2019. Dallas was ranked number 5 with 40, San Antonio was tied for 11th on the list with 28, Fort Worth came it at number 12 with 27, while El Paso is tied for 14th on the list with 25.

When it comes to states with the most dog attacks, California tops the list for the second straight year with 777, with Texas coming in a distant second with 491 attacks.

The good news is that the number of USPS employees attacked is down nationwide with 5,803 attacks, which is over 200 fewer than 2018 and more than 400 fewer than 2017. Lets hope the downward trend continues.

Go here to read the rest:
Texas City Tops the List of Dog Attacks on Postal Workers in US - Newstalk1290

Posted in Post Human | Comments Off on Texas City Tops the List of Dog Attacks on Postal Workers in US – Newstalk1290

This Essay Collection is a Roadmap Toward A Healthier Post-COVID Food System – Food Tank

Posted: at 12:56 am

Contributing Author:Jared Kaufman

After the COVID-19 pandemic, we cant go back to normal. Normal was a broken food system that left vulnerable communities behind and hurt our natural biodiverse ecosystems.

How do we rebuild a food system thats truly regenerative and restorative? How do we create systems that are not just diverse but truly inclusive? How do we feed a growing population without sacrificing our fragile planet?

Throughout the pandemic, Ive been hosting Food Talk Live conversations twice daily, and Ive spoken with countless farmers, chefs, journalists, scientists, entrepreneurs, sustainable business leaders, and other food system stakeholders. From these conversations, Ive realized we need to blend technology with traditional wisdom, make the invisible visible, recognize the power of food as medicine, and use both our forks and our ballots to vote for a healthier food system.

In the journal Agriculture and Human Values, over 80 inspiring researchers and advocates share their own insights into how COVID-19 has impacted the food system and how we move forward. The essay collection, which Food Tank was honored to help organize along with many other brilliant folks, is available for everyone to read for free.

Food Tank is highlighting some of the articles from this series that pave the way toward a more equitable and sustainable post-COVID food system.

1. Alison Hope Alkon, Sarah Bowen, Yuki Kato, and Kara Alexis Young, food justice and equity scholars, on unequal vulnerability to COVID

While stark racial health disparities predate COVID-19, if we continue to turn a blind eye to the classism and racism embedded within our food system, these disparities will inevitably widen as this pandemic weaves its way through the population, write Alison Hope Alkon, Sarah Bowen, Yuki Kato, and Kara Alexis Young. They analyze the racial disparities in COVID-19 vulnerability through a food justice framework, noting that diet-related risk factors for the disease are not the result of a persons individual choices but rather the racial capitalist structures that constrain a persons food access.

2. Ana Moragues-Faus, political economist of food, on building distributive food economies

Spain was hit hard and early by COVID-19, and national responses reinforced a monolithic and industrial version of the modern food system. But communities challenged this with distributive food practices such as mutual aid programs, interconnected webs of relationships within the food system, and local agroecology, according to Ana Moragues-Faus, a professor of the political economy of food at Universitat de Barcelona in Spain. The pandemic represents and opportunity to nurture and invest in distributive food economies, she argues.

3. Bill McKibben, climate change scientist, on playing by natures rules

Farmers inherently understand the need to pay attention to nature, environmentalist and Middlebury College professor Bill McKibben writes. But most of us have lost touch with the fickleness of a world we cant control. We can wish things were different all we want, he says, but this only delays our action and allows the problem to get worsewhether COVID-19 or climate change. As it turns out, you cant spin a virus, you cant talk it down, you cant force it to compromise or negotiate, he writes. Biology sets limits and we have to respect them, not the other way around.

4. Edie Mukiibi of Slow Food International on food security in Africa

While African countries are enacting restrictions to stop the spread of COVID-19, the impact of the pandemic on peoples ability to access food has been an afterthought, writes Edie Mukiibi, the vice president of Slow Food International and executive director of Slow Food Uganda. This is particularly pronounced in urban areas, where shortages and skyrocketing prices are significant barriers. For Africa to handle the emerging and post COVID-19 food security crisis, we need to strategically focus on giving the necessary support and facilities to communities of producers, fishers, pastoralists, indigenous people and other key grassroot players in the food system, he writes.

5. Elizabeth Hoover, Indigenous foodways scholar, on Native nations responses to the pandemic

Indigenous nations around the U.S. have struggled with food insecurity for years, and often dont receive policy help they need, writes Brown University professor Elizabeth Hoover. In this essay, Hoover highlights steps Native leaders around the country are taking to help their communitiescreating educational programs, pushing for support for local food networks, building local seed sovereignty, and more.

6. Elizabeth Mpofu, general coordinator of Via Campesina, on how globalization leaves peasant farmers behind

Peasant food systems are crucial to building defence against crises, writes Elizabeth Mpofu, a Zimbabwean organic farmer and the general coordinator of Via Campesina, a global organization of peasant farmers. Mpofu writes that Via Campesina is fighting for a food system thats more harmonious with nature and stands up for the right to food sovereignty for peasant farmers.

7. Gary Paul Nabhan, ethnobotanist and seed saving advocate, on how COVID will change crops

After the pandemic, the food we eat will neither look nor taste the same as what we are eating today, writes Gary Paul Nabhan, the co-founder of Native Seeds/SEARCH. Why? Because, he says, the breakdown of our siloed food system will lead us to develop agricultural landscapes with a greater diversity of soil microbes and plant species. People will grow more of their own food and get used to eating produce that looks imperfect. And as we grow foods on our own fertile soil with our own seeds, Nabhan says, well learn what seasonal crops are actually supposed to taste like.

8. Jeff Moyer, CEO of The Rodale Institute, on how soil health equals human health

In 1942, Rodale Institute founder J.I. Rodale said, Healthy Soil=Healthy Food=Healthy People. This is as true now as ever, Rodale Institute CEO Jeff Moyer writes. The Rodale Institute works to build regenerative, organic farming methods that revitalize the soil, which Moyer says has been neglected by conventional agriculture. With a goal of human health starting with the soil, together we will achieve a future that prioritizes health as the primary metric of agricultural success, he writes.

9. Julian Aygeman and Alexandra Duprey, urban food justice scholars, on protecting undocumented immigrants during COVID

Sanctuary cities are urban areas that have committed to protecting undocumented immigrants from federal deportation or prosecution. But what are sanctuary cities doing to protect undocumented immigrants from the pandemic? Not enough, argue Julian Agyeman and Alexandra Duprey, faculty in Urban and Environmental Policy and Planning at Tufts University. Immigrant communities are generally facing compounding trauma during the COVID-19 pandemic, they write. They offer concrete steps cities can take to address this.

10. Leah Penniman, Black farmer and food sovereignty advocate, on how food can be liberation

This nation has relied upon the labor, expertise, and resources of BIPOC [Black, Indigenous, and people of color] communities to undergird the food system since its inception, writes Leah Penniman, the founder of Soul Fire Farm. This means the industrialized food system is steeped in racism, injustice, and unequal access to resources and opportunities. By land redistribution, mutual aid, and dignified food access, Black and Indigenous communities can free themselves from what Penniman calls the system of food apartheid.

11. Mary Hendrickson, rural food systems researcher, on the dangers of agribusiness consolidation

Power in the agri-food system is concentrated in the hands of a few global companies like Bayer and Cargilland the pandemic has exposed how brittle such a centralized, non-diversified system is, says University of Missouri rural sociologist Mary Hendrickson. Our only hope is that the precarity of the system, its potential losing of its core identity as a for-profit food system based on efficiency, specialization, standardization and centralization, will allow transition to a decentralized, diverse, and interconnected food system that can feed all of us now and in the future, she writes.

12. Patrick Holden, farmer and sustainability advocate, on a healthier local food economy

Health is not merely the absence of disease but rather a vital state when an organism, plant, animal or human, is living in a dynamic balance with its external environment, writes Patrick Holden, a farmer in Wales and the founder of Sustainable Food Trust. He argues a better nourished population, with a more sustainable food system, could have been better equipped to battle COVID-19. The light at the end of the tunnel, he writes, is that local food systems offer increased food security at a time of serious existential threats.

Read this article:
This Essay Collection is a Roadmap Toward A Healthier Post-COVID Food System - Food Tank

Posted in Post Human | Comments Off on This Essay Collection is a Roadmap Toward A Healthier Post-COVID Food System – Food Tank

AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent…

Posted: at 12:45 am

ALAMEDA, Calif. & SEATTLE--(BUSINESS WIRE)-- AgeX Therapeutics, Inc.. (AgeX: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and Pluristyx, Inc. (Seattle, WA), an advanced therapy tools and services company serving customers in the rapidly growing fields of regenerative medicine and cellular and gene therapies, today announced they have entered into a Manufacturing, Marketing, and Distribution Agreement through which Pluristyx will undertake these activities on behalf of AgeX with respect to AgeXs research- and clinical-grade ESI brand human embryonic stem cells, sometimes referred to as hESCs.

The agreement builds on Pluristyxs strategy to manufacture, market, and distribute high-quality standardized Ready-to-Use and Ready-to-Differentiate pluripotent stem cells to industry and academic scientists intent on developing therapeutic products to treat human disease. AgeXs ESI hESC lines are distinguished for being the first clinical-grade hESC lines created under current Good Manufacturing Practice (cGMP). The AgeX ESI hESC lines are listed on the National Institutes of Health (NIH) Stem Cell Registry and are among the best characterized and documented stem cell lines available worldwide.

The agreement is a key step in AgeXs licensing and collaboration strategy to facilitate industry and academic access to its hESC lines, its PureStem cell derivation and manufacturing platform, and its UniverCyte immunotolerance technology in order to generate near- and long-term revenues.

A recent FDA IND clearance for a biotech company to begin a human trial for a cell therapy candidate derived from an AgeX ESI hESC line has amplified interest from industry and academia to utilize our cells in regenerative medicine. It is AgeXs goal to make its cell lines the gold standard when it comes to therapeutic products derived from pluripotent stem cells. We are delighted to be working with the Pluristyx team given their extensive cGMP manufacturing experience with pluripotent stem cells, said Dr. Nafees Malik, Chief Operating Officer of AgeX.

Pluristyx is excited to be working with AgeX and their ESI hESC lines. As AgeX intends to make their cell lines the gold standard, our aim is to disrupt and redefine stem cell therapy manufacturing with our proprietary, high-density format, Ready-to-Use and Ready-to-Differentiate hESC lines, which will dramatically reduce both cost and time in translating revolutionary therapies from bench to bedside, said Dr. Benjamin Fryer, CEO of Pluristyx.

Academic and biopharma organizations will need to obtain separate commercial licenses from AgeX in order to advance their cellular product candidates generated from AgeX hESC lines into human clinical trials and commercialization. AgeX retains all rights to manufacture its own in-house cellular products as well as to extend license rights to other third parties.

About AgeX Therapeutics

AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. Its PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeXs core product pipeline is intended to extend human healthspan. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.

For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.

About Pluristyx

Established in 2018, Pluristyx Inc. is a privately held, early-stage company providing a complete cell manufacturing solution. As an advanced therapy tools company, Pluristyx helps companies and researchers solve manufacturing challenges in the field of drug development, regenerative medicine, and cell and gene therapy. Pluristyx is led by a team with decades of industry experience each with specific expertise in key areas needed to develop and manufacture pluripotent stem cells. Pluristyx provides know how in every stage of the process from cell banking through scale-up of clinical grade material as well as all aspects of process development and manufacturing.

For more information, please visit http://www.pluristyx.com or connect with the company on Twitter and LinkedIn.

Forward-Looking Statements for AgeX

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. In addition, with respect to AgeXs Manufacturing, Marketing and Distribution Agreement with Pluristyx there is no assurance that (i) Pluristyx will generate significant sales of AgeX ESI hESC lines, or (ii) AgeX will derive significant revenue from sales of ESI hESC lines by Pluristyx. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200616005377/en/

View post:
AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent...

Posted in Immortality Medicine | Comments Off on AgeX Therapeutics and Pluristyx Announce Manufacturing, Marketing, and Distribution Agreement to Expand Access to Clinical-Grade Human Pluripotent…

Avoid eating these artificial preservatives whenever possible – Yahoo Lifestyle

Posted: at 12:45 am

Food Flashexplores the wild world of food news, from the health benefits of red wine to why dark chocolate is actually good for you.

Our favorite foods all have a shelf life, but did you know that many of them are living far beyond their original expiration date?

Thanks to artificial preservatives, fruits, vegetables, meats and dairy products last much longer now than they naturally would, and that is not necessarily good news.

Not all preservatives are bad for you, of course. Humans have been using natural preservatives like salt and sugar for thousands of years to keep food from spoiling,

Be cautious with artificial preservatives, though. According to Healthline, many of them can have harmful effects on your health.

Sulfites, for example, are used to prevent discoloration, but they have been linked to asthma.

Sodium benzoate is found in sodas and used in fermentation, but its also considered a carcinogen.

Nitrite, another carcinogen, gives hot dogs their unique red color.

Try avoiding preservatives as much as you can by shopping for organic, fresh and naturally labeled products.

If you enjoyed this story, you might also like reading abouthow our favorite foods of today have a secret past.

More from In The Know:

Were sorry to say this fast-food restaurant map is totally fake

This queer-owned brand will make you rethink womens clothing

You can use Sephora Insider points to donate to a Black nonprofit

15 of our favorite retailers that are selling fabric face masks

The post Avoid eating these artificial preservatives whenever possible appeared first on In The Know.

Excerpt from:
Avoid eating these artificial preservatives whenever possible - Yahoo Lifestyle

Posted in Immortality Medicine | Comments Off on Avoid eating these artificial preservatives whenever possible – Yahoo Lifestyle

Practical Ideas for Farming on the Moon and Mars – Universe Today

Posted: June 14, 2020 at 11:50 am

When the International Space Station (ISS) runs low on basic supplies like food, water, and other necessities they can be resupplied from Earth in a matter of hours. But when astronauts go the Moon for extended periods of time in the coming years, resupply missions will take much longer to get there. The same holds true for Mars, which can take months to get there while also being far more expensive.

Its little wonder then why NASA and other space agencies are looking to develop methods and technologies that will ensure that their astronauts have a degree of self-sufficiency. According to NASA-supported research conducted by Daniel Tompkins of Grow Mars and Anthony Muscatello (formerly of the NASA Kennedy Space Center), ISRU methods will benefit immensely from some input from nature.

Tompkins and Dr. Muscatello began their collaborative relationship in 2018 shortly after the latter retired from NASA KSC, where he spent the previous two decades working on chemical systems for In-Situ Resource Utilization (ISRU) applications. Later that year, Muscatello delivered a speech at the annual Mars Society Convention on the subject of how Mars could be terraformed using oxygen and self-replicating robots.

Shortly thereafter, Tompkins contacted Dr. Muscatello and the two began collaborating on a project designed to improve conventional ISRU techniques. With the support of researchers from NASA KSC, the NASA Jet Propulsion Laboratory, the Moon Village Association, and The Bionetics Corporation, Tompkins and Muscatello produced a joint study describing their approach.

This study was presented at the tenth joint meeting of the Planetary & Terrestrial Mining Sciences Symposium (June 11th-14th, 2019), which coinciding with the 20th anniversary of the Space Resources Roundtable (SRR). Here, the pair described how traditional ISRU techniques used to establish a lunar base could be vastly improved by incorporating growing and self-replicating living organisms (aka. the Green Moon concept).

As Dr. Muscatello described it to Universe Today via email:

GrowMars is based on biological processes to make oxygen from CO2 with chemical processing of the algae to convert it to the starting products to make polymers for structural applications. Conventional ISRU is based on physical and chemical processes only.

The pair detailed this concept further in a peer-reviewed study that addressed how these same biological and agricultural methods could be used to create vast greenhouses on Mars (aka. GrowMars). In this process, algae is grown in greenhouses that use locally-harvested water, atmospheric CO2 (on Mars), waste CO2 from human respiration and waste, or CO2 and carbon monoxide (CO) from lunar cold traps, and sunlight.

This biomass, which is rich in carbohydrates, is then fed into a conversion reactor to produce polyethylene furandicarboxylate (PEF), a bioplastic derived from carbohydrates (C8H6O). This bioplastic can be used as a bonding agent that is then combined with lunar or Martian regolith to create a polymer composite concrete, which in turn is used as feedstock for robotic 3D printers to create more greenhouses.

According to their greenhouse design, the composite building material is printed out to make transparent blocks that are rectangular (lengthwise) and trapezoidal (crosswise). This shape optimizes the absorption of solar energy by ensuring that the greenhouses can constantly be tilted towards the Sun and allows for the blocks to be tessellated (stacked with no space between them) to form larger structures.

As Tompkins explained the process to Universe Today via email:

Biomass to plastic conversion is well studied and practiced in an effort to make sustainable and petroleum independent plastics. Basically, the carbohydrate portion of biomass is processed into clear plastics at a high rate with low power and mass required. [The] key thing to note [is that] not all bioderived plastics are biodegradable.

In short, this bioplastic can be generated using sugars (rather than petrochemicals) and is durable enough for off-world use. Between that and the shape they are printed in, the blocks can be combined to create many different types of structures. This includes homes and parks for human settlers as well as additional greenhouses.

Over time, these new greenhouses could grow more algae to create more blocks, thus growing a colony over time. When placed over natural depressions, like craters or extended valleys (aka. fossae, which are common on Mars), they can work as both greenhouses and radiation shields. In fact, the ability to shield against harmful radiation is one of the most beneficial aspects of this system.

Traditionally, radiation shielding consists of metal panels (like lead) since they have a good weight-to-protection ratio. Whereas barriers made of other materials can also block cosmic and solar rays, they typically have to be very thick to do so. Unfortunately, metal panels do not protect crews from the secondary particles that result from collisions, which create secondary particles that will shower crews.

By comparison, water and plastic have been shown to be effective at blocking radiation while generating no secondary particles the same holds true of bioplastics. The only impediment is, natural barriers need to be up to 3 m (~10 ft) thick in order to reliably protect against solar and cosmic rays. But with a tessellated structure that also acts as a dome, a colony would have all the natural shielding it requires.

In addition, the conversion reactor also creates useful byproducts, like proteins, lipids (fat cells), and minerals that can be used in the manufacture of chemical fertilizers (nitrogen, phosphorous, potassium, calcium, magnesium, iron, etc.) On top of that, says Tompkins, they can be used to manufacture other crucial resources like food, oxygen, biofuel, rocket fuel the list goes on.

As Dr. Muscatello summarized the process:

GrowMars generates more of the polymer blocks in which the algae grows, thereby expanding the oxygen and polymer production capacity exponentially with time, up to the limits of the algae-to-polymer process units, which can be over-sized in anticipation of this aspect if desired. The algae replicates itself as long as CO2, water, and a small amount of fertilizer are provided.

Conventional ISRU is always limited to the capacities of the as-built systems, i.e. to get more production, more units are required. Thus, the algae-based system could have mass and power advantages over conventional ISRU. The algae based systems can also be configured to provide radiation shielding with the water and polymer blocks.

When it comes to Project Artemis and NASAs long-term vision of creating a program of sustainable lunar exploration, one of the principal focuses is on how local resources can be leveraged to provide self-sufficiency. The same holds true for mission architectures to Mars and the outer Solar System. In all cases, the plan is to harvest water ice, regolith, and other local resources so that resupply missions can be few and far between.

Traditional ISRU techniques are focused primarily on harnessing locally-available resources, like water ice and regolith. In contrast, this new approach focuses on how harnessing local water and minerals, as well as energy from the Sun, and carbon dioxide and carbon monoxide from human waste, to multiply local resource potential.

As Tompkins put it, this technique would ensure the production of more food and better building materials:

We are leveraging these efforts in the space context with unique functionality of being carbon negative, (producing net oxygen), enabling more photosynthesis area, radiation protection, building material, all in an expanding loop system that is biologically and functionally integrated. All with the hope of self-sufficiency and outpacing entropy at a basic needs level.

Bio-based systems have the potential to reduce the mass and power required to provide oxygen and polymers while having the ability to expand their production rates, thus reducing the costs of launch mass, the volume launched, and power requirements, added Dr. Muscatello. Such advantages can make exploration and settlement less expensive and faster.

Many of the ideas presented by Tompkins and Muscatello were also touched on by Dr. Robert Zubrin in a recent study that appeared on Centauri Dreams titled Sublake Settlements for Mars. In addition to being an aerospace engineer and the founder of the Mars Society, Dr. Zubrin is also a noted advocate for the exploration, colonization, and terraforming of Mars.

In this essay, Zubrin presents a variation on the paraterraforming concept, where sections of a planet are enclosed and ecologically engineered to be habitable. Specifically, he explored how settlements could be built within ice-filled craters on Mars, where the lower layers of ice could be melted to create a subglacial lake. Over time, the presence of warm water and organic molecules could allow for the formation of a biosphere.

Housing created within the lake would benefit from the fact that the external pressure would be similar to Earths atmosphere (100 kPa, or 1 bar). This is preferable in many ways to habitats built on the surface, where atmospheric pressure is (on average) about 0.5% what we experience here on Earth. On top of that, the thick ice and deep water would provide all the necessary radiation shielding for a settlement to survive.

Taken as a while, Tompkins and Muscatellos concept for growing settlement on the Moon and Mars represents a practical and scalable concept for off-world colonies. But perhaps some of the most exciting implications of this study is the impact it could have here on Earth. As Tompkins reminds us, the innovation that resulted from the Apollo Program resulted in countless applications here at home.

These applications were made possible thanks to NASAs Technology Transfer Program and have been cataloged since 1976 by NASA Spinoff. Whereas the Apollo Program resulted in commercial, medical, and industrial applications ranging from microwave ovens, heart monitors, and MRIs to GPS and Lidar. This time, NASAs goals call for innovations that can ensure self-sufficiency, sustainability, and cost-effectiveness.

Based on current UN projections, Earths population is expected to peak at 10 billion by the year 2050. Simultaneously, climate change will continue to disrupt the very systems humans depend upon for their very livelihood and survival. The only way to prevent the worst from happening (widespread famine, economic collapse, mass migrations, etc.) is to employ technologies that allow us to do more with less.

Its not hard to see how technologies that can leverage biomass to create petroleum-free plastics (as well as fertilizers and food) will be a boon for future generations. There are also parallels between this technology and the work of Stanford Professor Steven Chu, former Energy Secretary for the Obama administration and the man who proposed the Glucose Economy, an alternative to the current petroleum-based economy.

In the near future, Tompkins and Muscatello are hoping to secure additional funding so they can mount a full-cycle demonstration of the technology. If all goes well, this type of biomass-to-bioplastics and farming method could become a regular feature of lunar and Martian colonies. It could even become a regular feature of life here on Earth.

As always, our efforts to send humans into space are yielding tangible benefits here at home. And when the technology designed to address what is needed to survive out there also addresses some of our greatest needs down here, those benefits can be enormous.

Further Reading: GrowMars, Space Resources Roundtable study, Peer-reviewed study, Centauri Dreams

Like Loading...

The rest is here:
Practical Ideas for Farming on the Moon and Mars - Universe Today

Posted in Mars Colonization | Comments Off on Practical Ideas for Farming on the Moon and Mars – Universe Today

Longevity And Anti-Senescence Therapy Market Worldwide Growth Survey Size COVID-19 2023 – Cole of Duty

Posted: June 13, 2020 at 3:17 pm

Theglobal longevity and anti-senescence therapies marketshould grow from $329.8 million in 2018 to $644.4 million by 2023 with a compound annual growth rate (CAGR) of 14.3% during 2018-2023.

Report Scope:

The scope of this report is broad and covers various therapies currently under trials in the global longevity and anti-senescence therapy market. The market estimation has been performed with consideration for revenue generation in the forecast years 2018-2023 after the expected availability of products in the market by 2023. The global longevity and anti-senescence therapy market has been segmented by the following therapies: Senolytic drug therapy, Gene therapy, Immunotherapy and Other therapies which includes stem cell-based therapies, etc.

Revenue forecasts from 2028 to 2023 are given for each therapy and application, with estimated values derived from the expected revenue generation in the first year of launch.

Request for Report Sample:https://www.trendsmarketresearch.com/report/sample/11698

The report also includes a discussion of the major players performing research or the potential players across each regional longevity and anti-senescence therapy market. Further, it explains the major drivers and regional dynamics of the global longevity and anti-senescence therapy market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major vendors and potential entrants in the global longevity and anti-senescence therapy market.

Report Includes:

71 data tables and 40 additional tables An overview of the global longevity and anti-senescence therapy market Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023 Country specific data and analysis for the United States, Canada, Japan, China, India, U.K., France, Germany, Spain, Australia, Middle East and Africa Detailed description of various anti-senescence therapies, such as senolytic drug therapy, gene therapy, immunotherapy and other stem cell therapies, and their influence in slowing down aging or reverse aging process

Coverage of various therapeutic drugs, devices and technologies and information on compounds used for the development of anti-ageing therapeutics A look at the clinical trials and expected launch of anti-senescence products Detailed profiles of the market leading companies and potential entrants in the global longevity and anti-senescence therapy market, including AgeX Therapeutics, CohBar Inc., PowerVision Inc., T.A. Sciences and Unity Biotechnology

Summary

Global longevity and anti-senescence therapy market deals in the adoption of different therapies and treatment options used to extend human longevity and lifespan. Human longevity is typically used to describe the length of an individuals lifetime and is sometimes used as a synonym for life expectancy in the demography. Anti-senescence is the process by which cells stop dividing irreversibly and enter a stage of permanent growth arrest, eliminating cell death. Anti-senescence therapy is used in the treatment of senescence induced through unrepaired DNA damage or other cellular stresses.

Global longevity and anti-senescence market will witness rapid growth over the forecast period (2018-2023) owing to an increasing emphasis on Stem Cell Research and an increasing demand for cell-based assays in research and development.

An increasing geriatric population across the globe and a rising awareness of antiaging products among generation Y and later generations are the major factors expected to promote the growth of global longevity and anti-senescence market. Factors such as a surging level of disposable income and increasing advancements in anti-senescence technologies are also providing traction to the global longevity and anti-senescence market growth over the forecast period (2018-2023).

According to the National Institutes of Health (NIH), the total geriatric population across the globe in 2016 was over REDACTED. By 2022, the global geriatric population (65 years and above) is anticipated to reach over REDACTED. An increasing geriatric population across the globe will generate huge growth prospectus to the market.

Senolytics, placenta stem cells and blood transfusions are some of the hot technologies picking up pace in the longevity and anti-anti-senescence market. Companies and start-ups across the globe such as Unity Biotechnology, Human Longevity Inc., Calico Life Sciences, Acorda Therapeutics, etc. are working extensively in this field for the extension of human longevity by focusing on study of genomics, microbiome, bioinformatics and stem cell therapies, etc. These factors are poised to drive market growth over the forecast period.

Global longevity and anti-senescence market is projected to rise at a CAGR of REDACTED during the forecast period of 2018 through 2023. In 2023, total revenues are expected to reach REDACTED, registering REDACTED in growth from REDACTED in 2018.

The report provides analysis based on each market segment including therapies and application. The therapies segment is further sub-segmented into Senolytic drug therapy, Gene therapy, Immunotherapy and Others. Senolytic drug therapy held the largest market revenue share of REDACTED in 2017. By 2023, total revenue from senolytic drug therapy is expected to reach REDACTED. Gene therapy segment is estimated to rise at the highest CAGR of REDACTED till 2023. The fastest growth of the gene therapy segment is due to the Large investments in genomics. For Instance; The National Human Genome Research Institute (U.S.) had a budget grant of REDACTED for REDACTED research projects in 2015, thus increasing funding to REDACTED for approximately REDACTED projects in 2016.

More Info of Impact [emailprotected]https://www.trendsmarketresearch.com/report/covid-19-analysis/11698

Read the original post:
Longevity And Anti-Senescence Therapy Market Worldwide Growth Survey Size COVID-19 2023 - Cole of Duty

Posted in Human Longevity | Comments Off on Longevity And Anti-Senescence Therapy Market Worldwide Growth Survey Size COVID-19 2023 – Cole of Duty

Global Precision Medicine Software Market Growth Factor Analysis by Manufacturers, Shares, Size, Trends and Challenges with Forecast to 2026 – 3rd…

Posted: at 3:17 pm

Global Precision Medicine Software Market Report helps the readers to maximize their profits and business making ventures by gaining complete insights of Precision Medicine Software Industry. The latest developments and growth opportunities in Precision Medicine Software Industry are covered. Development trends, revenue analysis, Global Precision Medicine Software market share and market dynamics are presented to optimize the business.

The vital Precision Medicine Software insights, opportunities in existing and emerging segments are explained. An in-depth analysis of the present state of Precision Medicine Software, progressive future trends, and comprehensive analysis based on Precision Medicine Software type, application, players and regions are covered. The report thoroughly analyzes the Precision Medicine Software competitors, SWOT analysis, industry chain structure and production process view.

Get A Free Sample Copy Here: https://www.globalmarketers.biz/report/others/global-precision-medicine-software-market-report-2019,-competitive-landscape,-trends-and-opportunities/136862#request_sample

The top Precision Medicine Software industry players are:

SOPHiA GENETICS SA (Switzerland)N-of-One, Inc. (US)Gene42, Inc. (Canada)LifeOmic Health, LLC (US)Translational Software, Inc. (US)IBM Watson Group (US)2bPrecise LLC (Israel)Roper Technologies(US)Koninklijke Philips N.V. (Netherlands)Qiagen(Germany)Foundation Medicine, Inc. (US)Pfizer, Inc., Merck & Co., Inc.(US)NantHealth, Inc. (US)Allscripts(US)Sunquest Information Systems Inc. (US)Human Longevity, Inc. (US)Abbott Laboratories(US)Tempus Labs, Inc. (US)GlaxoSmithKline plc(UK)Sanofi S.A.(France)Fabric Genomics (US)Syapse, Inc. (US)PierianDx, Inc. (US)Flatiron Health, Inc. (US)AstraZeneca plc(US)

The report begins with an introduction, definition, objectives, and Global Precision Medicine Software market scope. The industry size is estimated based on market value, revenue, concentration ratio and Precision Medicine Software growth rate. The report covers major trends, drivers, restraints which will depict the market growth during the forecast period. The complete perspective in terms of Precision Medicine Software revenue, geographical regions namely North America, Europe, Asia-Pacific, Middle-East & Africa, and South America is portrayed. The key information on distributors and suppliers of Precision Medicine Software industry represents the present and forecast trends.

Global Precision Medicine Software Market news, plans & policies, market drivers, analysis of upstream raw material suppliers and downstream buyers of Precision Medicine Software is carried out in this report. On regional and country level market share, production value, gross margin analysis, consumption ratio, import-export scenario, and SWOT analysis is covered. Global Precision Medicine Software Market forecast study enlists the market value (in USD) and volume forecast for each region, product type, and applications.

The business approach and growth statistics implemented by Global Precision Medicine Software industry competitors will lead to a competitive edge in the industry. The production and demand statistics of Precision Medicine Software driven by evolving market segments across different regions, type and application are mentioned in this report. The value chain analysis and market share for varied Precision Medicine Software players are covered. The consumption statistics for the mentioned type, applications and regions are enclosed in the report. This report will help you in analyzing the industry scenario and characteristics of Global Precision Medicine Software market.

Inquiry Here For Detail Report @ https://www.globalmarketers.biz/report/others/global-precision-medicine-software-market-report-2019,-competitive-landscape,-trends-and-opportunities/136862#inquiry_before_buying

segment and subsegment are given below

Types of Global Precision Medicine Software Market:

Cloud-basedOn-premise

Applications of Global Precision Medicine Software Market:

Healthcare providersResearch centers & Government institutesPharmaceutical & Biotechnology companiesOther end users

Any query? Enquire Here For Discount :https://www.globalmarketers.biz/discount_inquiry/discount/136862

Main Highlights Of the Global Precision Medicine Software Market Report:

1. The report offers an analytical study on various global Precision Medicine Software industries to provide decisive data.

2. The top market segment analysis and Precision Medicine Software market drivers are explained in this report.

3. A mix of primary and secondary research methodology provides authentic and reliable data.

4. A separate section is dedicated to Precision Medicine Software competitive scenario and market statistics.

5. The clear and concise study on Precision Medicine Software dynamics, cost structures will yield useful results.

6. Latest developments and trends in Precision Medicine Software are evaluated in this report.

7. This study offers past, present and forecasts information on Precision Medicine Software Market. The data is represented in form of tables, infographics, charts to provide an easier view.

Report Summary:

In the first section, the Precision Medicine Software report presents industry overview, definition, and scope. The second part briefs about the Precision Medicine Software industry bifurcation by Type, Application and Geographical regions. The top industry players, market share and sales margin is explained. The raw materials analysis, production and consumption scenario is specified. The SWOT analysis by players, the growth rate for each type and the region is covered. A 5-year forecast data of Precision Medicine Software Market perspective will lead to profitable business plans and informed moves. Towards, the end data sources, research methodology, and findings are offered.

Why Select This Report:

Complete analysis on market dynamics, market status, and competitive Precision Medicine Software view is offered.

Forecast Precision Medicine Software Industry trends will present the market drivers, constraints and growth opportunities.

All vital Precision Medicine Software Industry verticals are presented in this study like Product Type, Applications and Geographical Regions.

The five-year forecast view shows how the market is expected to grow in coming years.

Complete market dynamics will facilitate key insights for informed decision making.

To know More Details About Precision Medicine Software Market research Report @: https://www.globalmarketers.biz/report/others/global-precision-medicine-software-market-report-2019,-competitive-landscape,-trends-and-opportunities/136862#table_of_contents

Link:
Global Precision Medicine Software Market Growth Factor Analysis by Manufacturers, Shares, Size, Trends and Challenges with Forecast to 2026 - 3rd...

Posted in Human Longevity | Comments Off on Global Precision Medicine Software Market Growth Factor Analysis by Manufacturers, Shares, Size, Trends and Challenges with Forecast to 2026 – 3rd…

Covid-19 Impact Analysis on Precision Medicine Software Market and Scope and Opportunities in Coming Years | Syapse, Allscripts, Qiagen, Roper…

Posted: at 3:17 pm

Precision Medicine Software Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above. Market forecasts will provide deep insight into industry parameters by accessing growth, consumption, upcoming market trends and various price fluctuations.

Global Precision Medicine Software Market research reports growth rates and market value based on market dynamics, growth factors. Complete knowledge is based on the latest innovations in the industry, opportunities and trends. In addition to SWOT analysis by key suppliers, the report contains a comprehensive market analysis and major players landscape.

Ask for Sample Copy of This Report: https://healthcareintelligencemarkets.com/request_sample.php?id=32273

Top Key Players Included in This Report: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health etc.

The report on the Global Precision Medicine Software Market has newly added by Research N Reports to its huge repository. The market is expected to increase by the end of forecast period. Primary and secondary research methodologies have been used for curating this research report.

Major highlights of this research report:

-In-depth analysis of the degree of competition across the globe.

-Estimation of Global Precision Medicine Software Market values and volumes.

Global Precision Medicine Software Market analysis through industry analysis tools such as SWOT and Porters five analysis.

-Business profiling of prominent companies across the global regions like North America, Latin America, Middle East, Asia-Pacific, Africa, and Europe.

-Detailed elaboration on global market value, volume, and penetration.

Global Precision Medicine Software Market growth projections.

-Detailed description on development policies and plans.

-Analytical study on drivers, restraints, opportunities, hindrances, inadequacies, challenges and strengths.

Get Discount on This Report: https://healthcareintelligencemarkets.com/ask_for_discount.php?id=32273

The global regions which are scrutinized for a clear understanding of Global Precision Medicine Software Market are North America, Latin America, Asia-Pacific, Africa, Europe, and India. The research on the Global Precision Medicine Software Market will be applicable to investors, business owners, industry experts, and various c level peoples. Profiling of the several top-level industries has been included in this informative report.

The research study has taken the help of graphical presentation techniques such as info graphics, charts, tables, and pictures. It provides guidelines for both established players and new entrants in the Global Precision Medicine Software Market.

If you have any special requirements, please let us know and we will offer you the report as per your requirements.

For Any Customization, Ask Our Experts: https://healthcareintelligencemarkets.com/enquiry_before_buying.php?id=32273

Table of Contents:

Healthcare Intelligence Market:

HealthCare Intelligence Markets Reports provides Market intelligence and consulting services to global customers in 145 countries. Being a B2B company, we help businesses respond boldly to evolving Market challenges. Create customized syndicated Market research reports to help Market players build strategies to change games. In addition, reports on the pharmaceutical development, clinical and healthcare IT industries provide future trends and future Market prospects.

Contact Us:

Marvella Lit

Phone number: + 44-753-712-1342

Address: 90 State Office Center

90 State Street Suite 700, Albany, NY 12207

sales@healthcareintelligenceMarkets.com

http://www.healthcareintelligenceMarkets.com

See the original post here:
Covid-19 Impact Analysis on Precision Medicine Software Market and Scope and Opportunities in Coming Years | Syapse, Allscripts, Qiagen, Roper...

Posted in Human Longevity | Comments Off on Covid-19 Impact Analysis on Precision Medicine Software Market and Scope and Opportunities in Coming Years | Syapse, Allscripts, Qiagen, Roper…

(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

Posted: at 3:17 pm

Precision Medicine SoftwareMarket 2020: Inclusive Insight

Los Angeles, United States,June 2020:The report titled Global Precision Medicine Software Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Precision Medicine Software market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Precision Medicine Software market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Precision Medicine Software market is carefully analyzed and researched about by the market analysts.

Precision Medicine Software Market competition by top manufacturers/ Key player Profiled: Syapse, Allscripts, Qiagen, Roper Technologies, Fabric Genomics, Foundation Medicine, Sophia Genetics, PierianDx, Human Longevity, Translational Software, Gene42, Inc, Lifeomic Health

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/867663

Global Precision Medicine Software Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020- 2025. According to the latest report added to the online repository of Alexareports the Precision Medicine Software market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Based on region, the globalPrecision Medicine Software market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Precision Medicine Software Market Segment by Type covers: Cloud-based, On-premise

Precision Medicine Software Market Segment by Industry: Healthcare Providers, Pharmaceutical and Biotechnology Companies, Research Centers and Government Institutes, Others

After reading the Precision Medicine Software market report, readers get insight into:

*Major drivers and restraining factors, opportunities and challenges, and the competitive landscape*New, promising avenues in key regions*New revenue streams for all players in emerging markets*Focus and changing role of various regulatory agencies in bolstering new opportunities in various regions*Demand and uptake patterns in key industries of the Precision Medicine Software market*New research and development projects in new technologies in key regional markets*Changing revenue share and size of key product segments during the forecast period*Technologies and business models with disruptive potential

Key questions answered in the report:

What will the market growth rate of Precision Medicine Software market?What are the key factors driving the global Precision Medicine Software market size?Who are the key manufacturers in Precision Medicine Software market space?What are the market opportunities, market risk and market overview of the Precision Medicine Softwaremarket?What are sales, revenue, and price analysis of top manufacturers of Precision Medicine Software market?Who are the distributors, traders, and dealers of Precision Medicine Software market?What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Softwareindustries?What are sales, revenue, and price analysis by types and applications of Precision Medicine Softwaremarket?What are sales, revenue, and price analysis by regions of Precision Medicine Software industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/867663

Table of ContentsSection 1 Precision Medicine Software Product DefinitionSection 2 Global Precision Medicine Software Market Manufacturer Share and Market Overview2.1 Global Manufacturer Precision Medicine Software Shipments2.2 Global Manufacturer Precision Medicine Software Business Revenue2.3 Global Precision Medicine Software Market Overview2.4 COVID-19 Impact on Precision Medicine Software IndustrySection 3 Manufacturer Precision Medicine Software Business Introduction3.1 Syapse Precision Medicine Software Business Introduction3.1.1 Syapse Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.1.2 Syapse Precision Medicine Software Business Distribution by Region3.1.3 Syapse Interview Record3.1.4 Syapse Precision Medicine Software Business Profile3.1.5 Syapse Precision Medicine Software Product Specification3.2 Allscripts Precision Medicine Software Business Introduction3.2.1 Allscripts Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Allscripts Precision Medicine Software Business Distribution by Region3.2.3 Interview Record3.2.4 Allscripts Precision Medicine Software Business Overview3.2.5 Allscripts Precision Medicine Software Product Specification3.3 Qiagen Precision Medicine Software Business Introduction3.3.1 Qiagen Precision Medicine Software Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Qiagen Precision Medicine Software Business Distribution by Region3.3.3 Interview Record3.3.4 Qiagen Precision Medicine Software Business Overview3.3.5 Qiagen Precision Medicine Software Product Specification3.4 Roper Technologies Precision Medicine Software Business Introduction3.5 Fabric Genomics Precision Medicine Software Business Introduction3.6 Foundation Medicine Precision Medicine Software Business IntroductionSection 4 Global Precision Medicine Software Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Precision Medicine Software Market Size and Price Analysis 2014-20194.1.2 Canada Precision Medicine Software Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Precision Medicine Software Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Precision Medicine Software Market Size and Price Analysis 2014-20194.3.2 Japan Precision Medicine Software Market Size and Price Analysis 2014-20194.3.3 India Precision Medicine Software Market Size and Price Analysis 2014-20194.3.4 Korea Precision Medicine Software Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Precision Medicine Software Market Size and Price Analysis 2014-20194.4.2 UK Precision Medicine Software Market Size and Price Analysis 2014-20194.4.3 France Precision Medicine Software Market Size and Price Analysis 2014-20194.4.4 Italy Precision Medicine Software Market Size and Price Analysis 2014-20194.4.5 Europe Precision Medicine Software Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Precision Medicine Software Market Size and Price Analysis 2014-20194.5.2 Africa Precision Medicine Software Market Size and Price Analysis 2014-20194.5.3 GCC Precision Medicine Software Market Size and Price Analysis 2014-20194.6 Global Precision Medicine Software Market Segmentation (Region Level) Analysis 2014-20194.7 Global Precision Medicine Software Market Segmentation (Region Level) AnalysisSection 5 Global Precision Medicine Software Market Segmentation (Product Type Level)5.1 Global Precision Medicine Software Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Precision Medicine Software Product Type Price 2014-20195.3 Global Precision Medicine Software Market Segmentation (Product Type Level) AnalysisSection 6 Global Precision Medicine Software Market Segmentation (Industry Level)6.1 Global Precision Medicine Software Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Precision Medicine Software Market Segmentation (Industry Level) AnalysisSection 7 Global Precision Medicine Software Market Segmentation (Channel Level)7.1 Global Precision Medicine Software Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Precision Medicine Software Market Segmentation (Channel Level) AnalysisSection 8 Precision Medicine Software Market Forecast 2019-20248.1 Precision Medicine Software Segmentation Market Forecast (Region Level)8.2 Precision Medicine Software Segmentation Market Forecast (Product Type Level)8.3 Precision Medicine Software Segmentation Market Forecast (Industry Level)8.4 Precision Medicine Software Segmentation Market Forecast (Channel Level)Section 9 Precision Medicine Software Segmentation Product Type9.1 Cloud-based Product Introduction9.2 On-premise Product IntroductionSection 10 Precision Medicine Software Segmentation Industry10.1 Healthcare Providers Clients10.2 Pharmaceutical and Biotechnology Companies Clients10.3 Research Centers and Government Institutes Clients10.4 Others ClientsSection 11 Precision Medicine Software Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/867663

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Visit link:
(2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

Posted in Human Longevity | Comments Off on (2020-2025) Precision Medicine Software Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

Cellular Reprogramming Tools Market to Witness Robust Expansion Throughout the F – News.MarketSizeForecasters.com

Posted: at 3:17 pm

Market Study Report, LLC, adds a comprehensive research of the ' Cellular Reprogramming Tools market' that mentions valuable insights pertaining to market share, profitability graph, market size, SWOT analysis, and regional proliferation of this industry. This study incorporates a disintegration of key drivers and challenges, industry participants, and application segments, devised by analyzing profuse information about this business space.

The research report on Cellular Reprogramming Tools market provides a granular assessment of this business vertical and includes information concerning the market tendencies such as revenue estimations, current remuneration, market valuation, and market size over the estimated timeframe.

Request a sample Report of Cellular Reprogramming Tools Market at:https://www.marketstudyreport.com/request-a-sample/2701683?utm_source=marketsizeforecasters.com&utm_medium=ADS

An overview of the performance assessment of the Cellular Reprogramming Tools market is enlisted. The document also comprises of crucial insights pertaining to the major industry trends and the expected growth rate of the said market. The study encompasses specifics related to the growth avenues as well as the restraining factors for this business space.

Major factors underlined in the Cellular Reprogramming Tools market report:

Considering the geographical landscape of the Cellular Reprogramming Tools market:

Cellular Reprogramming Tools Market Segmentation: North America, Europe, Asia-Pacific & Middle East and Africa.

A summary of the details offered in the Cellular Reprogramming Tools market report:

Ask for Discount on Cellular Reprogramming Tools Market Report at:https://www.marketstudyreport.com/check-for-discount/2701683?utm_source=marketsizeforecasters.com&utm_medium=ADS

An overview of the Cellular Reprogramming Tools market in terms of product type and application scope:

Product landscape:

Product types: Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells and Other

Key parameters included in the report:

Application Spectrum:

Application segmentation: Drug Development, Regenerative Medicine, Toxicity Test, Academic Research and Other

Specifics offered in report:

Additional information mentioned in the report:

Other insights regarding the competitive scenario of the Cellular Reprogramming Tools market:

Vendor base of Cellular Reprogramming Tools market: Celgene, FUJIFILM Holdings, BIOTIME, Advanced Cell Technology, Mesoblast, Human Longevity, Cynata, STEMCELL Technologies, Astellas Pharma, Osiris Therapeutics, EVOTEC and Japan Tissue Engineering

Key parameters as per the report:

Highlights of the report:

Key questions answered in the report:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-cellular-reprogramming-tools-market-growth-status-and-outlook-2020-2025

Some of the Major Highlights of TOC covers:

Chapter 1: Methodology & Scope

Definition and forecast parameters

Methodology and forecast parameters

Data Sources

Chapter 2: Executive Summary

Business trends

Regional trends

Product trends

End-use trends

Chapter 3: Cellular Reprogramming Tools Industry Insights

Industry segmentation

Industry landscape

Vendor matrix

Technological and innovation landscape

Chapter 4: Cellular Reprogramming Tools Market, By Region

Chapter 5: Company Profile

Business Overview

Financial Data

Product Landscape

Strategic Outlook

SWOT Analysis

Related Reports:

2. Global Deuterium-substituteddrugs Market Growth (Status and Outlook) 2020-2025Deuterium-substituteddrugs Market report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market.Read More: https://www.marketstudyreport.com/reports/global-deuterium-substituteddrugs-market-growth-status-and-outlook-2020-2025

Read More Reports On: https://www.marketwatch.com/press-release/global-public-safety-drones-market-size-to-show-robust-growth-through-2027-2020-06-12?tesla=y

Read More Reports On: https://www.marketwatch.com/press-release/global-industrial-refrigeration-equipment-market-size-to-witness-prominent-gains-during-2020-2026-2020-06-06?tesla=y

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Go here to see the original:
Cellular Reprogramming Tools Market to Witness Robust Expansion Throughout the F - News.MarketSizeForecasters.com

Posted in Human Longevity | Comments Off on Cellular Reprogramming Tools Market to Witness Robust Expansion Throughout the F – News.MarketSizeForecasters.com

Page 1,261«..1020..1,2601,2611,2621,263..1,2701,280..»